NCATS received input from stakeholder communities on how the CTSA Program might be strengthened to deliver on its promise to develop, demonstrate and disseminate innovative approaches, methodologies and interventions that translate into improved human health. Feedback was received from a diverse audience including: general feedback from CTSA Program review panel, Working Groups and Public & CTSA Program Consortium members via Request for Information (RFI) in October 2019, including feedback from academic centers (individuals and institutions); advocacy groups; medical and scientific societies; not-for-profit, integrated health system; and an NIH institute. Over 100 comments were received. We have published the responses to the feedback via an Information Session accessible through the following URL: https://www.youtube.com/watch?v=GgIppY4ba54&feature=youtu.be. Please provide feedback regarding the session by “liking” (or not) the presentation in YouTube.
In addition, we recently issued a Notice of Change to Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)” NOT-TR-20-036. The purpose of this notice is to inform interested applicants in a change to the Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)”. The August 15, 2021 receipt date has been moved to July 15, 2021.